PXLR

N/A

Report date: 2024/10/21 13:30:52

Base Information

Drug NamePXLR

Drug Alias Nameanti-CXCLCR1/2/3/5 antibody (Chiome Bioscience)PXLR (Chiome Bioscience)PXLR

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionC-X-C motif chemokine receptor 1 antagonistsC-X-C motif chemokine receptor 2 antagonistsC-X-C motif chemokine receptor 3 antagonists

TargetsC-X-C motif chemokine receptor 1C-X-C motif chemokine receptor 2C-X-C motif chemokine receptor 3

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesChiome Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesChiome Bioscience Inc

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A